TITLE

A blistering disease: bullous erysipelas

AUTHOR(S)
Edwards, Janet; Green, Peter; Haase, David
PUB. DATE
August 2006
SOURCE
CMAJ: Canadian Medical Association Journal;8/1/2006, Vol. 175 Issue 3, p245
SOURCE TYPE
Academic Journal
DOC. TYPE
Case Study
ABSTRACT
Presents a case study of an aged man with non-insulin-dependent diabetes mellitus, who developed bullous erysipelas. Medical history of the patient; Clinical information on bullous erysipelas; Therapeutic management of the condition.
ACCESSION #
21678168

 

Related Articles

  • Is the Indicator Magnifying Window for Insulin Pens Helpful for Elderly Diabetic Patients? Ju Hee Lee; Eun Shil Hong; Jung Hun Ohn; Young Min Cho // Diabetes & Metabolism Journal;Apr2013, Vol. 37 Issue 2, p149 

    Patients with type 2 diabetes who require insulin therapy are commonly elderly and have poor visual acuity. In this study, we examined the clinical usefulness of the indicator magnifying window (1MW) for elderly patients with type 2 diabetes. We recruited 50 patients with type 2 diabetes over...

  • Effect of Acarbose on Insulin Sensitivity in Elderly Patients With Diabetes. Meneilly, Graydon S.; Ryan, Edmond A.; Radziuk, Jerry; Lau, David C.W.; Yale, Jean-Francois; Morais, Jose; Chiasson, Jean-Louis; Rabasa-Lhoret, Remi; Maheux, Pierre; Tessier, Daniel; Wolever, Thomas; Josse, Robert G.; Elahi, Dariush // Diabetes Care;Aug2000, Vol. 23 Issue 8, p1162 

    Presents information on a study which investigated the effect of acarbose, an alpha-glucosidase inhibitor, on insulin release and insulin sensitivity in elderly patients with type 2 diabetes. Account of related studies; Research design and methods; Conclusions.

  • Type II diabetes: A treatment approach for the older patient. Miller, Myron; Peterson, Monte // Geriatrics;Aug96, Vol. 51 Issue 8, p43 

    Discusses the treatment of noninsulin-dependent (type II) diabetes mellitus in older patients. Risk factors; Long-term complications of elevated blood glucose; Risk reduction by glucose control; Primary care strategies; Exam.

  • What Can We Do to Improve Physical Function in Older Persons With Type 2 Diabetes? Caruso, Lisa B.; Silliman, Rebecca A. // Journals of Gerontology Series A: Biological Sciences & Medical ;Jul2000, Vol. 55 Issue 7, pM372 

    Presents information on a study that identified factors associated with impaired physical function in elderly persons with type 2 diabetes in the United States. Effect of regular exercise and weight loss on functional status; Methodology; Results and discussion.

  • ABSTRACTS.  // Gerontologist;Oct2000 Special Issue, Vol. 40, p143 

    Presents several abstracts about diseases of the aged. `Is Type 2 Diabetes in the Elderly Associated With An Increased Risk of Cognitive Impairment?,' by R.D. Lindeman, L.J. Romero, A. LaRue, C.L. Yau, D.S. Schade, K.M. Koehler, R.N. Baumgartner and P.J. Garry; `Cognitive Abilities of...

  • Age-Related Diabetes Concern.  // JAMA: Journal of the American Medical Association;12/12/2012, Vol. 308 Issue 22, p2325 

    The article informs that according to a study, adults aged 65 years or above are more prone towards type 2 diabetes than any other age group.

  • Comparison of high fibre diets, basal insulin supplements, and flexible insulin treatment for non-insulin dependent (type II) diabetics poorly controlled with sulphonylureas. Scott, A.R.; Attenborough, Y.; Peacock, I.; Fletcher, E.; Jeffcoate, W.J.; Tattersall, R.B. // BMJ: British Medical Journal (International Edition);9/17/88, Vol. 297 Issue 6650, p707 

    Explores the efficacy of managements for non-insulin-dependent diabetes. Administration of high fiber diet, basal insulin supplements and a regimen of insulin for diabetics; Absence of changes in hemoglobin A[sub 1] concentration during high fiber diet; Improvement of control of diabetes by...

  • Combination Therapy for Type 2 Diabetes. Bell, David S. H. // American Family Physician;12/1/2001, Vol. 64 Issue 11, p1812 

    Editorial. Comments on the combination therapy for type 2 diabetes. Effectiveness of sulfonylurea as treatment for type 2 diabetes; Examination of the insulin therapy; Information on the combined insulin and oral therapy.

  • Pathogenesis of Type 2 Diabetes: Implications for Metformin. DeFronzo, R.A. // Drugs;Dec1999 Supplement 1, Vol. 58 Issue 6, p29 

    Discusses the implications of the pathogenesis of type 2 diabetes for metformin. Insulin resistance in type 2 diabetes mellitus individuals; Defects in insulin action; Information on the initial therapeutic approach in type 2 diabetes mellitus patients.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics